Literature DB >> 33367288

How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.

Martijn J Schuemie1,2,3, M Soledad Cepeda1,2, Marc A Suchard1,3,4,5, Jianxiao Yang1,4, Yuxi Tian1,4, Alejandro Schuler1,6, Patrick B Ryan1,2,7, David Madigan1,8, George Hripcsak1,7,9.   

Abstract

Healthcare professionals increasingly rely on observational healthcare data, such as administrative claims and electronic health records, to estimate the causal effects of interventions. However, limited prior studies raise concerns about the real-world performance of the statistical and epidemiological methods that are used. We present the "OHDSI Methods Benchmark" that aims to evaluate the performance of effect estimation methods on real data. The benchmark comprises a gold standard, a set of metrics, and a set of open source software tools. The gold standard is a collection of real negative controls (drug-outcome pairs where no causal effect appears to exist) and synthetic positive controls (drug-outcome pairs that augment negative controls with simulated causal effects). We apply the benchmark using four large healthcare databases to evaluate methods commonly used in practice: the new-user cohort, self-controlled cohort, case-control, case-crossover, and self-controlled case series designs. The results confirm the concerns about these methods, showing that for most methods the operating characteristics deviate considerably from nominal levels. For example, in most contexts, only half of the 95% confidence intervals we calculated contain the corresponding true effect size. We previously developed an "empirical calibration" procedure to restore these characteristics and we also evaluate this procedure. While no one method dominates, self-controlled methods such as the empirically calibrated self-controlled case series perform well across a wide range of scenarios.

Entities:  

Keywords:  causal effect estimation; evaluation; methods; observational research

Year:  2020        PMID: 33367288      PMCID: PMC7755157          DOI: 10.1162/99608f92.147cc28e

Source DB:  PubMed          Journal:  Harv Data Sci Rev        ISSN: 2644-2353


  62 in total

1.  Propensity score methods for confounding control in nonexperimental research.

Authors:  M Alan Brookhart; Richard Wyss; J Bradley Layton; Til Stürmer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-10

2.  Contradicted and initially stronger effects in highly cited clinical research.

Authors:  John P A Ioannidis
Journal:  JAMA       Date:  2005-07-13       Impact factor: 56.272

Review 3.  Desideratum for evidence based epidemiology.

Authors:  J Marc Overhage; Patrick B Ryan; Martijn J Schuemie; Paul E Stang
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

4.  Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.

Authors:  Patrick B Ryan; Martijn J Schuemie; David Madigan
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

5.  A comparison of the empirical performance of methods for a risk identification system.

Authors:  Patrick B Ryan; Paul E Stang; J Marc Overhage; Marc A Suchard; Abraham G Hartzema; William DuMouchel; Christian G Reich; Martijn J Schuemie; David Madigan
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

6.  Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents.

Authors:  Yiting Wang; Mehul Desai; Patrick B Ryan; Frank J DeFalco; Martijn J Schuemie; Paul E Stang; Jesse A Berlin; Zhong Yuan
Journal:  Diabetes Res Clin Pract       Date:  2017-04-13       Impact factor: 5.602

7.  Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance.

Authors:  G Niklas Norén; Ola Caster; Kristina Juhlin; Marie Lindquist
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

Review 8.  Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.

Authors:  Andrew Anglemyer; Hacsi T Horvath; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29

9.  Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data.

Authors:  Martijn J Schuemie; George Hripcsak; Patrick B Ryan; David Madigan; Marc A Suchard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-13       Impact factor: 11.205

10.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.

Authors:  Peter C Austin
Journal:  Pharm Stat       Date:  2011 Mar-Apr       Impact factor: 1.894

View more
  13 in total

1.  Synthetic Negative Controls: Using Simulation to Screen Large-scale Propensity Score Analyses.

Authors:  Richard Wyss; Sebastian Schneeweiss; Kueiyu Joshua Lin; David P Miller; Linda Kalilani; Jessica M Franklin
Journal:  Epidemiology       Date:  2022-04-12       Impact factor: 4.860

2.  Metformin Is Associated With a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared With Sulfonylureas: An Observational Study.

Authors:  Anna Ostropolets; Pierre A Elias; Michael V Reyes; Elain Y Wan; Utpal B Pajvani; George Hripcsak; John P Morrow
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-07

3.  Data Consult Service: Can we use observational data to address immediate clinical needs?

Authors:  Anna Ostropolets; Philip Zachariah; Patrick Ryan; Ruijun Chen; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2021-09-18       Impact factor: 7.942

4.  Characterizing database granularity using SNOMED-CT hierarchy.

Authors:  Anna Ostropolets; Christian Reich; Patrick Ryan; Chunhua Weng; Anthony Molinaro; Frank DeFalco; Jitendra Jonnagaddala; Siaw-Teng Liaw; Hokyun Jeon; Rae Woong Park; Matthew E Spotnitz; Karthik Natarajan; George Argyriou; Kristin Kostka; Robert Miller; Andrew Williams; Evan Minty; Jose Posada; George Hripcsak
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

5.  Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA.

Authors:  James Weaver; Azza Shoaibi; Huy Q Truong; Leila Larbi; Shujian Wu; Peter Wildgoose; Gowtham Rao; Amy Freedman; Lu Wang; Zhong Yuan; Elliot Barnathan
Journal:  Drug Saf       Date:  2021-03-02       Impact factor: 5.606

6.  Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis.

Authors:  Xintong Li; Lana Yh Lai; Anna Ostropolets; Faaizah Arshad; Eng Hooi Tan; Paula Casajust; Thamir M Alshammari; Talita Duarte-Salles; Evan P Minty; Carlos Areia; Nicole Pratt; Patrick B Ryan; George Hripcsak; Marc A Suchard; Martijn J Schuemie; Daniel Prieto-Alhambra
Journal:  Front Pharmacol       Date:  2021-11-24       Impact factor: 5.810

7.  Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.

Authors:  Kristin Kostka; Talita Duarte-Salles; Albert Prats-Uribe; Anthony G Sena; Andrea Pistillo; Sara Khalid; Lana Y H Lai; Asieh Golozar; Thamir M Alshammari; Dalia M Dawoud; Fredrik Nyberg; Adam B Wilcox; Alan Andryc; Andrew Williams; Anna Ostropolets; Carlos Areia; Chi Young Jung; Christopher A Harle; Christian G Reich; Clair Blacketer; Daniel R Morales; David A Dorr; Edward Burn; Elena Roel; Eng Hooi Tan; Evan Minty; Frank DeFalco; Gabriel de Maeztu; Gigi Lipori; Hiba Alghoul; Hong Zhu; Jason A Thomas; Jiang Bian; Jimyung Park; Jordi Martínez Roldán; Jose D Posada; Juan M Banda; Juan P Horcajada; Julianna Kohler; Karishma Shah; Karthik Natarajan; Kristine E Lynch; Li Liu; Lisa M Schilling; Martina Recalde; Matthew Spotnitz; Mengchun Gong; Michael E Matheny; Neus Valveny; Nicole G Weiskopf; Nigam Shah; Osaid Alser; Paula Casajust; Rae Woong Park; Robert Schuff; Sarah Seager; Scott L DuVall; Seng Chan You; Seokyoung Song; Sergio Fernández-Bertolín; Stephen Fortin; Tanja Magoc; Thomas Falconer; Vignesh Subbian; Vojtech Huser; Waheed-Ul-Rahman Ahmed; William Carter; Yin Guan; Yankuic Galvan; Xing He; Peter R Rijnbeek; George Hripcsak; Patrick B Ryan; Marc A Suchard; Daniel Prieto-Alhambra
Journal:  Clin Epidemiol       Date:  2022-03-22       Impact factor: 4.790

8.  Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics.

Authors:  Perrine Janiaud; Arnav Agarwal; Ioanna Tzoulaki; Evropi Theodoratou; Konstantinos K Tsilidis; Evangelos Evangelou; John P A Ioannidis
Journal:  BMC Med       Date:  2021-07-06       Impact factor: 11.150

9.  Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS.

Authors:  Daniel Prieto-Alhambra; Kristin Kostka; Talita Duarte-Salles; Albert Prats-Uribe; Anthony Sena; Andrea Pistillo; Sara Khalid; Lana Lai; Asieh Golozar; Thamir M Alshammari; Dalia Dawoud; Fredrik Nyberg; Adam Wilcox; Alan Andryc; Andrew Williams; Anna Ostropolets; Carlos Areia; Chi Young Jung; Christopher Harle; Christian Reich; Clair Blacketer; Daniel Morales; David A Dorr; Edward Burn; Elena Roel; Eng Hooi Tan; Evan Minty; Frank DeFalco; Gabriel de Maeztu; Gigi Lipori; Heba Alghoul; Hong Zhu; Jason Thomas; Jiang Bian; Jimyung Park; Jordi Martínez Roldán; Jose Posada; Juan M Banda; Juan P Horcajada; Julianna Kohler; Karishma Shah; Karthik Natarajan; Kristine Lynch; Li Liu; Lisa Schilling; Martina Recalde; Matthew Spotnitz; Mengchun Gong; Michael Matheny; Neus Valveny; Nicole Weiskopf; Nigam Shah; Osaid Alser; Paula Casajust; Rae Woong Park; Robert Schuff; Sarah Seager; Scott DuVall; Seng Chan You; Seokyoung Song; Sergio Fernández-Bertolín; Stephen Fortin; Tanja Magoc; Thomas Falconer; Vignesh Subbian; Vojtech Huser; Waheed-Ul-Rahman Ahmed; William Carter; Yin Guan; Yankuic Galvan; Xing He; Peter Rijnbeek; George Hripcsak; Patrick Ryan; Marc Suchard
Journal:  Res Sq       Date:  2021-03-01

10.  The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.

Authors:  Melissa A Haendel; Christopher G Chute; Tellen D Bennett; David A Eichmann; Justin Guinney; Warren A Kibbe; Philip R O Payne; Emily R Pfaff; Peter N Robinson; Joel H Saltz; Heidi Spratt; Christine Suver; John Wilbanks; Adam B Wilcox; Andrew E Williams; Chunlei Wu; Clair Blacketer; Robert L Bradford; James J Cimino; Marshall Clark; Evan W Colmenares; Patricia A Francis; Davera Gabriel; Alexis Graves; Raju Hemadri; Stephanie S Hong; George Hripscak; Dazhi Jiao; Jeffrey G Klann; Kristin Kostka; Adam M Lee; Harold P Lehmann; Lora Lingrey; Robert T Miller; Michele Morris; Shawn N Murphy; Karthik Natarajan; Matvey B Palchuk; Usman Sheikh; Harold Solbrig; Shyam Visweswaran; Anita Walden; Kellie M Walters; Griffin M Weber; Xiaohan Tanner Zhang; Richard L Zhu; Benjamin Amor; Andrew T Girvin; Amin Manna; Nabeel Qureshi; Michael G Kurilla; Sam G Michael; Lili M Portilla; Joni L Rutter; Christopher P Austin; Ken R Gersing
Journal:  J Am Med Inform Assoc       Date:  2021-03-01       Impact factor: 7.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.